Global rheumatoid arthritis diagnostics market is expected to reach US$ 827.68 million by 2029, growing at a CAGR of 6.4% over the next eight years. The annual incidence of rheumatoid arthritis is approximately 3 cases per 10,000 populations, worldwide and the prevalence rate is approximately 1%, increasing with age and peaking between the ages of 35 and 50 years. Such factors are expected to assist the overall rheumatoid arthritis diagnostics market over the forecast period.
Commercialization of Rapid Diagnostic Test Kits and Assays by Market Participants
The One-Step Test is intended to use as practical/routine screening test that can be done in a few minutes. This test kit is specifically designed to detect antibodies against Rheumatoid Factors (IgA, IgM and IgG) by use of a Rapid Immunochromatic Assay. The kit should be stored at room temperature or refrigerated (2-30°C). The test strip is stable through the expiration date printed on the sealed pouch. The RF latex test kit ( Serology kit) is intended for the qualitative and semi-quantitative measurement of RF in human serum. Rheumatoid factor detection is based on the ability of rheumatoid arthritis sera to agglutinate sensitized sheep red cells. It’s estimated that more than two million Americans have rheumatoid arthritis, which can develop for months without showing any symptoms. At-home CCP-IgG screening test by imware analyzes citrullinated peptide antibody (CCP-IgG) and 2 rheumatoid arthritis (RF) biomarkers, all in the same sample, to accurately detect its presence. It’s available via online/e-commerce sales channel. Such factors are expected to assist the overall rheumatoid arthritis diagnostics market over the next eight years.
Request a sample Copy@ https://www.absolutemarketsinsights.com/request_sample.php?id=887
Serology segment captured the highest share in 2020
Serological diagnostic testing is of growing importance in the early detection and differentiation of rheumatoid arthritis. Apart from the traditional detection of the rheumatoid factor, new specific autoantibodies to citrullinated antigens have made a crucial contribution to the diagnosis of RA. One of the most important serological discoveries in rheumatology in recent years has been the characterization of autoantigens in RA containing the amino acid citrulline. The starting point for this discovery was the identification of the target antigen for anti-keratin antibodies. Two serological point-of-care tests (POCT) for the early detection of RA have been very recently developed. The Rheuma-Chec test combines two biomarkers for the diagnosis of RA—rheumatoid factor and antibodies to MCV. Antibodies to CCP are detected with the CCPoint assay (Euro-Diagnostica). The tests require only a single drop of whole blood and any general physician can perform them within minutes. The future will show whether these tests can bring additional improvements in diagnostic testing, leading to earlier therapy for RA. Immunoassays to detect anti-MCV and anti-CCP antibodies exhibit similar diagnostic sensitivity and specificity. Such factors is expected to assist the overall rheumatoid arthritis diagnostics market over the forecast period.
Enquiry Before Buying@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=887
The Impact of Covid-19 on the Rheumatoid Arthritis Diagnostics Market
Patients with rheumatic diseases do have a higher prevalence rate of catching several comorbidities such as advanced age, chronic pulmonary and kidney disease, heart disease, hypertension, obesity, and diabetes. It has been duly reported that the risk of severe COVID-19 was similar among patients with rheumatologic diseases compared with matched controls. A large cohort of United States veterans, a diagnosis of rheumatoid arthritis was associated with an increased risk of COVID-19 and COVID-19-related hospitalization or death compared with patients without rheumatoid arthritis. Such factors have aided the rheumatoid arthritis diagnostics market in the recent years and are expected to continue a similar trend over the forecast period.
Request for Customization@
https://www.absolutemarketsinsights.com/request_for_customization.php?id=887
Rheumatoid Arthritis Diagnostics Market:
- By Offering
- Assays
- Instruments and Systems
- Others
- By Age Group
- Below 30 Years
- 30 Years to 50 Years
- Above 50 Years
- By Test Type
- Serology
- Anti-CCP Antibody Test
- Rheumatoid Factor (RF)
- Antinuclear Antibodies (ANAs)
- Uric Acid
- Acute Phase Reactants
- C-reactive Protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
- Imaging Tests
- X-ray
- Magnetic Resonance Imaging (MRI)
- Ultrasound Imaging
- Computed Tomography (CT) Scanning
- Others
- Others
- Serology
- By End Users
- Hospitals
- Diagnostics Centres
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
For More Information Click@ https://www.absolutemarketsinsights.com/reports/Rheumatoid-Arthritis-Diagnostics-Market-2021---2029-887
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/